Stockreport

NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report

NKGen Biotech, Inc.  (NKGN) 
PDF SANTA ANA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), today announced it received a standard notice (the [Read more]